Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-15-413017
Filing Date
2015-12-23
Accepted
2015-12-23 17:25:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d60489d424b3.htm 424B3 290202
2 GRAPHIC g60489g02w63.jpg GRAPHIC 7010
3 GRAPHIC g60489g21y77.jpg GRAPHIC 172115
  Complete submission text file 0001193125-15-413017.txt   538077
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-208331 | Film No.: 151306535
SIC: 2834 Pharmaceutical Preparations